HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chester A Mathis Selected Research

2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)

3/2014Amyloid burden and neural function in people at risk for Alzheimer's Disease.
1/2014Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
11/2013Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
11/2013Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.
4/2013Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.
11/2012Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.
9/2012Amyloid imaging in dementias with atypical presentation.
3/2012Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
4/2011Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.
1/2011Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Chester A Mathis Research Topics

Disease

58Alzheimer Disease (Alzheimer's Disease)
01/2016 - 02/2002
15Amyloid Plaque
11/2013 - 02/2002
13Dementia (Dementias)
01/2016 - 12/2003
7Atrophy
03/2014 - 08/2005
7Anorexia Nervosa
02/2013 - 06/2004
5Bulimia Nervosa
02/2013 - 06/2004
4Parkinson Disease (Parkinson's Disease)
10/2013 - 12/2003
4Eating Disorders (Eating Disorder)
02/2013 - 06/2004
3Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
11/2015 - 03/2007
2Frontotemporal Lobar Degeneration (Semantic Dementia)
11/2015 - 01/2008
2Brain Injuries (Brain Injury)
01/2014 - 09/2007
2Anorexia
02/2013 - 05/2005
2Neoplasms (Cancer)
01/2013 - 10/2004
2Cocaine-Related Disorders (Cocaine Addiction)
01/2012 - 12/2011
2Bulimia (Binge Eating)
09/2005 - 06/2004
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1Multiple System Atrophy
11/2015
1Tauopathies
11/2015
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2015
1Amyloidosis
08/2015
1Carcinoma (Carcinomatosis)
01/2013
1Down Syndrome (Down's Syndrome)
11/2012
1Trisomy (Trisomies)
11/2012
1Disease Progression
11/2010
1Schizophrenia (Dementia Praecox)
02/2009
1Hemorrhage
09/2007
1Gliosis
09/2007
1Stroke (Strokes)
09/2007
1Contusions
09/2007
1Major Depressive Disorder (Major Depressive Disorders)
07/2007
1Viremia
08/2006
1Demyelinating Diseases (Demyelinating Disease)
06/2006
1Colorectal Neoplasms (Colorectal Cancer)
10/2004
1Colonic Neoplasms (Colon Cancer)
10/2004
1Prion Diseases (Transmissible Spongiform Encephalopathies)
07/2004
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
07/2004

Drug/Important Bio-Agent (IBA)

55Amyloid (Amyloid Fibrils)IBA
01/2016 - 02/2002
222- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
03/2014 - 06/2003
8Biological Markers (Surrogate Marker)IBA
01/2016 - 12/2009
8Serotonin (5 Hydroxytryptamine)IBA
02/2013 - 06/2004
6N- methyl- 2- (4'- methylaminophenyl)- 6- hydroxybenzothiazoleIBA
01/2015 - 01/2008
5Dopamine (Intropin)FDA LinkGeneric
02/2013 - 12/2005
4Glucose (Dextrose)FDA LinkGeneric
01/2016 - 01/2008
4PK 11195 (PK11195)IBA
08/2009 - 04/2004
3Amyloid beta-PeptidesIBA
01/2009 - 01/2006
2bapineuzumabIBA
08/2015 - 04/2010
2ApolipoproteinsIBA
08/2015 - 11/2010
2CarbonIBA
01/2014 - 01/2009
2Deoxyglucose (2 Deoxy D glucose)IBA
11/2013 - 11/2009
2LigandsIBA
09/2013 - 07/2004
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
02/2013 - 12/2007
2RacloprideIBA
02/2013 - 12/2005
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 10/2004
25-HT1A Serotonin ReceptorIBA
09/2011 - 09/2005
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
05/2007 - 06/2004
2AcetylcholinesteraseIBA
05/2005 - 12/2003
1protein TDP-43 (TDP-43)IBA
11/2015
1DNA-Binding Proteins (DNA Binding Protein)IBA
11/2015
1SynucleinsIBA
11/2015
1Apolipoproteins E (ApoE)IBA
08/2015
1CholesterolIBA
04/2014
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2014
1TritiumIBA
01/2014
1Contrast MediaIBA
10/2013
1alpha-SynucleinIBA
10/2013
1RheniumIBA
03/2013
1pivalyloxymethyl butyrateIBA
02/2013
1Epidermal Growth Factor (EGF)IBA
01/2013
1ThymidineIBA
01/2013
1PresenilinsIBA
11/2012
1Coloring Agents (Dyes)IBA
11/2012
1Amphetamine (Amfetamine)FDA LinkGeneric
03/2012
1GTP-Binding Proteins (G-Protein)IBA
12/2011
1Antidepressive Agents (Antidepressants)IBA
09/2011
1Deoxycytidine (CDR)IBA
12/2009
1amyloid beta-protein (1-42)IBA
06/2009
1gamma-Aminobutyric Acid (GABA)IBA
02/2009
1hydroxide ionIBA
01/2008
1Complement System Proteins (Complement)IBA
01/2008
1DAA 1106IBA
09/2007
1GABA-A Receptors (GABA(A) Receptor)IBA
09/2007
1Hashimoto's encephalitisIBA
06/2006
1Congo RedIBA
01/2006
11,4- bis(3- carboxy- 4- hydroxyphenylethenyl)- benzeneIBA
01/2006
1Proteins (Proteins, Gene)IBA
01/2006
1Presenilin-1IBA
11/2005
1WAY 100635IBA
09/2005
1ThymineIBA
10/2004
1Fluorouracil (Carac)FDA LinkGeneric
10/2004
1UracilIBA
10/2004
1Thymidylate SynthaseIBA
10/2004
12'-fluoro-5-methylarabinosyluracil (Clevudine)IBA
10/2004
1ProdrugsIBA
10/2004
1Acquired CJDIBA
07/2004
11,4- bis(4'- hydroxystyryl)- 2- methoxybenzeneIBA
07/2004

Therapy/Procedure

2Heterologous Transplantation (Xenotransplantation)
01/2013 - 10/2004
2Therapeutics
10/2007 - 09/2002
2Denervation
09/2007 - 01/2007
1Molecular Targeted Therapy
01/2013
1Drug Therapy (Chemotherapy)
09/2007